CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 15.60p |
Change Today | -0.15p |
% Change | -0.95 % |
52 Week High | 18.75 |
52 Week Low | 4.00 |
Volume | 290,503 |
Shares Issued | 113.66m |
Market Cap | £17.73m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:12 | 10,000 @ 15.78p |
12:57 | 350 @ 15.80p |
12:47 | 9 @ 16.50p |
12:47 | 226 @ 15.50p |
12:47 | 1,000 @ 15.50p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research